A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Urology Oncology Fellowship Bookmark and Share

Urology Oncology Fellowship

The Division of Urology and Urologic Oncology at City of Hope offers one- and two-year Fellowships in Urologic Oncology/Robotic Surgery with special emphasis on minimally invasive and robotic techniques. The one-year program includes one year of clinical work, while the two-year program includes one year of research and one year of clinical work.  Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena, in addition to their rotation at City of Hope.
 
City of Hope has had a tradition of training future urologic oncologic surgeons since 1992. Approximately 60 percent of our Fellows go on to careers in the academic setting.
 
Contact:
Clayton S. Lau, M.D.
Director,
Urologic Oncology Fellowship Program 
Division of Urology and Urologic Oncology

City of Hope

1500 East Duarte Road

Duarte, CA 91010-3000 

Phone: 626-256-4673 ext. 60521 

FAX: 626-301-8285
Email: cllau@coh.org
 
A request for additional information may be made to Christina Perez through email christinaperez@coh.org or send to the address above.
 
Eligibility
Candidates must be graduates of an ACGME-accredited urology program. There are currently three to four one-year clinical Fellowship positions available for board eligible/certified urologists. In addition, we have recently expanded the Fellowship and offer two-year Fellowships for those interested in enriching their training in basic science and outcomes research.
The two-year Fellows will spend the first twelve months in a lab working on translational research projects in Urologic Oncology/Robotic Surgery.  The second twelve months will be spent in a clinical Urology service.  During the clinical year, the Fellows participate in over 1,000 laparoscopic/robotic procedures, provide care for in-patients including ICU care, and offer continuity of care in the outpatient clinics.
 
Responsibilities
The Fellow is responsible for all in-patient care and typically operates four days per week with any one of the four current urologic oncology faculty members.  All urologic oncology faculty are Fellowship-trained and members of the Society of Urologic Oncology. The Fellow is currently supported clinically by a nurse practitioner and a physician assistant.
 
Completion of this program also mandates that our Fellows present at national meetings, write research papers, get involved with clinical trials, participate in journal clubs, and present lectures to the oncologic community. Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena in addition to their rotation at City of Hope.
 
Based on current occupancy levels, Fellows would be anticipated to participate in the surgical care and management of approximately 800 laparoscopic robotic radical prostatectomies; 75-80 laparoscopic cystoprostatectomies with urinary diversion; and 100-150 laparoscopic and robotic nephrectomies. A variety of other endoscopic, endourologic and general urology cases occur throughout the year.
 

While minimally invasive techniques are an important part of this program, our Fellows are also trained in complex open surgical techniques, such as post-chemotherapy RPLND’s, nephrectomies, open cystectomies and urinary tract reconstructions.  Because our Fellows train in a nationally recognized NCI-designated cancer center, they also have opportunities to participate in many multi-teamed procedures for abdominal and pelvic malignancies. Fellows are also exposed to a multidisciplinary treatment approach to urologic cancers by developing close relationships with radiation oncology, medical oncology, and uropathology.
 
City of Hope has one-year clinical and two-year research/clinical Fellowships available starting July 2016.  Interviews for these positions will be scheduled for January 2015.
 

Application Process

It is best to begin the application process about a year before your anticipated date of entry into the fellowship.
 
Interested parties should contact:
 
Christina Perez
Fellowship Coordinator
Division of Urology and Urologic Oncology
City of Hope
Email: christinaperez@coh.org
Phone: 626.256.4673 ext. 60521
Fax: 626-301-8285

Please note that before an interview date is scheduled, City of Hope must receive:
 
  • Current curriculum vitae,
  • Two letters of reference from faculty in the candidate’s residency-training program
  • Photo
  • Interviews will take place in January of 2015.

Urology Oncology Fellowship

Urology Oncology Fellowship

The Division of Urology and Urologic Oncology at City of Hope offers one- and two-year Fellowships in Urologic Oncology/Robotic Surgery with special emphasis on minimally invasive and robotic techniques. The one-year program includes one year of clinical work, while the two-year program includes one year of research and one year of clinical work.  Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena, in addition to their rotation at City of Hope.
 
City of Hope has had a tradition of training future urologic oncologic surgeons since 1992. Approximately 60 percent of our Fellows go on to careers in the academic setting.
 
Contact:
Clayton S. Lau, M.D.
Director,
Urologic Oncology Fellowship Program 
Division of Urology and Urologic Oncology

City of Hope

1500 East Duarte Road

Duarte, CA 91010-3000 

Phone: 626-256-4673 ext. 60521 

FAX: 626-301-8285
Email: cllau@coh.org
 
A request for additional information may be made to Christina Perez through email christinaperez@coh.org or send to the address above.
 
Eligibility
Candidates must be graduates of an ACGME-accredited urology program. There are currently three to four one-year clinical Fellowship positions available for board eligible/certified urologists. In addition, we have recently expanded the Fellowship and offer two-year Fellowships for those interested in enriching their training in basic science and outcomes research.
The two-year Fellows will spend the first twelve months in a lab working on translational research projects in Urologic Oncology/Robotic Surgery.  The second twelve months will be spent in a clinical Urology service.  During the clinical year, the Fellows participate in over 1,000 laparoscopic/robotic procedures, provide care for in-patients including ICU care, and offer continuity of care in the outpatient clinics.
 
Responsibilities
The Fellow is responsible for all in-patient care and typically operates four days per week with any one of the four current urologic oncology faculty members.  All urologic oncology faculty are Fellowship-trained and members of the Society of Urologic Oncology. The Fellow is currently supported clinically by a nurse practitioner and a physician assistant.
 
Completion of this program also mandates that our Fellows present at national meetings, write research papers, get involved with clinical trials, participate in journal clubs, and present lectures to the oncologic community. Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena in addition to their rotation at City of Hope.
 
Based on current occupancy levels, Fellows would be anticipated to participate in the surgical care and management of approximately 800 laparoscopic robotic radical prostatectomies; 75-80 laparoscopic cystoprostatectomies with urinary diversion; and 100-150 laparoscopic and robotic nephrectomies. A variety of other endoscopic, endourologic and general urology cases occur throughout the year.
 

While minimally invasive techniques are an important part of this program, our Fellows are also trained in complex open surgical techniques, such as post-chemotherapy RPLND’s, nephrectomies, open cystectomies and urinary tract reconstructions.  Because our Fellows train in a nationally recognized NCI-designated cancer center, they also have opportunities to participate in many multi-teamed procedures for abdominal and pelvic malignancies. Fellows are also exposed to a multidisciplinary treatment approach to urologic cancers by developing close relationships with radiation oncology, medical oncology, and uropathology.
 
City of Hope has one-year clinical and two-year research/clinical Fellowships available starting July 2016.  Interviews for these positions will be scheduled for January 2015.
 

Application Process

Application Process

It is best to begin the application process about a year before your anticipated date of entry into the fellowship.
 
Interested parties should contact:
 
Christina Perez
Fellowship Coordinator
Division of Urology and Urologic Oncology
City of Hope
Email: christinaperez@coh.org
Phone: 626.256.4673 ext. 60521
Fax: 626-301-8285

Please note that before an interview date is scheduled, City of Hope must receive:
 
  • Current curriculum vitae,
  • Two letters of reference from faculty in the candidate’s residency-training program
  • Photo
  • Interviews will take place in January of 2015.
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • Doctors often recommend preventive screenings for several cancers, based on hereditary or genetic factors, but brain tumors aren’t one of them. Primary brain tumors, which originate in the brain rather than spreading from another location, seem to develop at random, and doctors have little insight into wh...
  • Stopping cancer starts with research. To that end, STOP CANCER has awarded $525,000 in grants to City of Hope for 2015, supporting innovative research projects and recognizing the institution’s leadership in advancing cancer treatment and prevention. Founded in 1988, STOP CANCER underwrites the work of le...
  • Cancer may not be the disease many people think it is. Normally, cancer is considered to be a disease in which cells multiply at an extremely high, and unusual, rate – increasing the likelihood of genetic mutations. But increasingly, leading researchers at City of Hope and elsewhere are contending that cancer i...
  • “Of all forms of inequality, injustice in the health care system is the most shocking and inhumane.” By the time the Rev. Martin Luther King Jr. spoke those words in Chicago in 1966, the Civil Rights Act had been passed, the Voting Rights Act was the law of the land and the March on Washington was […]
  • Eight years ago, Matthew Loscalzo surprised himself by accepting the offer to become City of Hope’s administrative director of the Sheri & Les Biller Patient and Family Resource Center and executive director of the Department of Supportive Care Medicine. At the time, he was administrative director of the Sc...
  • The mental fog that patients can experience after undergoing chemotherapy treatment for cancer has a name: “chemo brain.” “Many patients report hearing or reading about chemotherapy-related cognitive deficits, but few are actually prepared to deal with these changes,” said Celina Lemon, M.A., an occupational th...
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...
  • Attention, parents! Only a few serious sunburns can increase a child’s ultimate risk of skin cancer. Further, some studies suggest that ultraviolet (UV) exposure before the age of 10 is the most important factor for melanoma risk. Here skin cancer expert Jae Jung, M.D., Ph.D., assistant professor in the D...
  • Esophagheal cancer may not be on many people’s radar, but heartburn probably is. The latter can ultimately lead to the former. More formally referred to as gastroesophageal reflux, heartburn occurs when stomach content makes its way back up into the esophagus, causing stomach acid to come into contact with the ...